Skip to main content
Premium Trial:

Request an Annual Quote

CDRD, PANAMP Join up for Therapeutics Development

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Canada's Centre for Drug Research and Development and the Pan Alberta Metabolomics Platform today announced the signing of a preferred collaboration agreement covering projects of mutual interest.

"This agreement is the starting point for both organizations to leverage each other's expertise and infrastructure: PANAMP's platform complementing CDRD's mandate to translated academic research into important therapeutics," said Karimah Es Sabar, senior vice president of business and strategic affairs for CDRD, in a statement.

Financial and other terms of the deal were not disclosed.

PANAMP calls itself a "distributed" core facility with expertise in metabolomic studies for clinical trials, biomedical studies, bioproduct studies, nutrient profiling, and environmental testing. It has access to more than C$5 million ($5.1 million) in state-of-the-art metabolomics infrastructure situated at the University of Alberta and the University of Calgary.

Supported by lab managers, NMR spectroscopists, mass spectrometrists, chemists, computer scientists, statisticians, and bioinformaticians, PANAMP can identify and quantify up to 2,000 different chemicals from certain biological samples, five times more comprehensive than other services currently available, CDRD said.

CDRD has a suite of drug development equipment and more than 20,000 square feet of lab space on the campuses of the University of British Columbia, Simon Fraser University, and the BC Cancer Agency.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.